Desmond G. Powe
Nottingham, ENG NG72UH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Correction: MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer.
Journal: Cell death & disease
Published: March 25, 2020
MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer.
Journal: Cell death & disease
Published: August 07, 2017
Erratum to: Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer.
Journal: Breast cancer research and treatment
Published: July 23, 2016
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer.
Journal: Breast cancer research and treatment
Published: February 10, 2016
KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer-a targeted molecular approach.
Journal: British journal of cancer
Published: December 31, 2015
Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.
Journal: The journal of pathology. Clinical research
Published: July 10, 2015
Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation.
Journal: Oncotarget
Published: June 17, 2014
Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study.
Journal: The British journal of dermatology
Published: February 04, 2014
Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer.
Journal: British journal of cancer
Published: November 04, 2013
β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 21, 2013
Last Updated: 09/26/2026